Immunization plays a critical role in keeping preteens and teens healthy and protected from vaccine-preventable diseases, including influenza, whooping cough, tetanus, diphtheria, meningococcal disease and cancers caused by human papillomavirus.

Rotavirus Experts Share Latest Research, Call for Increased Vaccine Coverage at Symposium

MINSK, BELARUS – Beginning today, the 13th International Rotavirus Symposium, hosted by the Sabin Vaccine Institute, the U.S. Centers for Diseases Control, PATH, ROTA Council, the Fogarty International Center at the U.S. National Institutes of Health, the Government of the Republic of Belarus, and the Bill & Melinda Gates Foundation, is bringing together scientific experts, policy makers and public health officials to share the latest developments in the fast-moving field of rotavirus prevention.
08.29.18 to 08.31.18
Minsk, Belarus

For 25 years, Sabin has been a trusted partner, working with countries, the World Health Organization (WHO), Gavi, the Vaccine Alliance, the Bill and Melinda Gates Foundation, and regional stakeholders to improve immunization.

When the Sabin Vaccine Institute’s Coalition against Typhoid held our most recent global conference in 2017, we could hardly have foreseen that it would be the

On April 23, 2018, 43 parliamentarians, joined by government officials and partners, gathered in Kinshasa, Democratic Republic of Congo, for a briefing on sustainable immunization financing.

During the last week in June, more than 200 members of the global immunization community, including stakeholders, partners and regional and country representatives, gathered in Kigali, Rwanda, for the 2018 Global Immunization Meeting.

The success of immunization programs relies heavily on immunization program managers, who facilitate every aspect of immunization programs, from cost-effective procurement of vaccines to the vigilant monitoring of vaccine safety and efficacy.

The worst U.S. flu season in a decade appears to be winding down, but the truth is, it’s always flu season. Even now, as Americans begin to put away the thermometers, hand sanitizers and cough drops, researchers are preparing for the next flu season. As early as February, they began trying to predict which influenza strains will dominate so they can create the right cocktail for next season’s vaccine.

Statement on New Universal Flu Vaccine Development Grand Challenge

WASHINGTON, D.C. – April 27, 2018 – The new $12 million Ending the Pandemic Threat: A Grand Challenge for Universal Influenza Vaccine Development from the Bill & Melinda Gates Foundation and Lucy and Larry Page is an important and necessary step toward finding a game-changing solution to end the threat of flu, according to experts at the Sabin Vaccine Institute (Sabin), a leading advocate for expanding vaccine access and uptake across the world. This challenge invites researchers from any discipline to submit innovative ideas for safe, effective, affordable flu vaccines.

Pages

Subscribe to RSS - Knowledge & Innovation